To include your compound in the COVID-19 Resource Center, submit it here.

Prometheus, Nestle deal

Nestle's Nestle Health Science S.A. subsidiary will acquire diagnostics and specialty pharma company Prometheus for an undisclosed sum. The Nestle unit, established in January to

Read the full 258 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE